通过免疫沉识别识别植物模式识别受体的酸化和蛋白质相互作用
Yasuhiro Kadota1, Ken Shirasu2,3
1RIKEN Center for Sustainable Resource Science (CSRS), RIKEN-TRIP, Yokohama, Kanagawa, Japan. yasuhiro.kadota@riken.jp.
Methods in molecular biology (Clifton, N.J.)
|February 5, 2026
概括
这项研究提出了一种优化的免疫沉协议,用于分析植物等离子体膜受体类激酶. 这种方法增强了对这些关键免疫受体的蛋白质相互作用和修改的研究.
科学领域:
- 植物免疫学 植物免疫学
- 分子植物病理学 分子植物病理学
- 生物化学 生物化学
背景情况:
- 血局部化的模式识别受体 (PRRs) 对植物免疫至关重要,检测病原体相关的分子模式 (PAMPs).
- 氨酸丰富的重复受体类激酶 (LRR-RLKs) 是关键的PRR,但它们的膜关联和低表达使生物化学研究复杂化.
- 传统的共同免疫沉 (Co-IP) 方法面临LRR-RLK不稳定性和疏水性质的挑战,阻碍了相互作用和修饰分析.
研究的目的:
- 开发和优化一个专门针对植物等离子体膜LRR-RLKs的免疫沉协议.
- 为了克服与研究这些膜结合受体相关的挑战,包括低表达和不稳定性.
- 为了方便对LRR-RLK交互原子和翻译后修改进行可靠的表征.
主要方法:
- 利用免疫沉技术的进步来隔离膜蛋白质.
- 开发了一种基于洗剂的提取和优化Co-IP协议,适用于LRR-RLKs.
- 应用了该协议,以便分析蛋白质-蛋白质相互作用和酸化动态.
主要成果:
- 成功优化了植物等离子体膜LRR-RLKs的免疫沉协议.
- 该协议允许对这些复杂的膜蛋白进行更稳定的分离和分析.
- 能够对相互作用的蛋白质进行可靠的识别,并对监管修改进行表征.
结论:
- 优化的协议显著改善了对植物等离子体膜LRR-RLKs的研究.
- 这一进步有助于更深入地了解植物免疫信号通路.
- 为未来关于LRR-RLK功能和调节的研究提供了有价值的工具.
相关概念视频
Phosphorylation
54.0K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
54.0K
G-protein Coupled Receptors
132.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
132.1K
Drug-Receptor Interactions
7.5K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.5K
Enzyme-linked Receptors
86.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
86.7K
Drug-Receptor Interaction: Antagonist
5.1K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
5.1K
Drug-Receptor Interaction: Agonist
4.1K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K


